Skip to content

Cognitive Training for Patients With Schizophrenia

Cognitive Training for Patients With Schizophrenia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01521026
Enrollment
69
Registered
2012-01-30
Start date
2003-09-30
Completion date
2009-08-31
Last updated
2023-07-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Other Primary Psychotic Disorders, Schizoaffective Disorder, Schizophrenia

Brief summary

This research on cognitive training addresses the following questions: 1. Does cognitive training lead to improved cognition, functional abilities, psychiatric symptoms, treatment adherence, or quality of life in patients with psychoses? 2. What are the neurocognitive and non-cognitive factors that predict good outcomes following cognitive rehabilitation? In addition to verbal learning and memory, immediate verbal memory, vigilance, and executive functioning, the cognitive training intervention attempted to improve prospective memory ability (i.e., the ability to remember to do things in the future, such as take medications or attend a doctor's appointment).

Interventions

BEHAVIORALCognitive Training

12-week compensatory cognitive training in group format

Sponsors

National Alliance for Research on Schizophrenia and Depression
CollaboratorOTHER
University of California, San Diego
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Primary psychotic disorder (including schizophrenia, schizoaffective disorder, psychotic mood disorder, or psychosis NOS) * Age 18 or older * Fluency in English

Exclusion criteria

* Dementia * Neurological conditions affecting cognition * Mental retardation * Substance use disorder within the past month * Participation in other intervention trials

Design outcomes

Primary

MeasureTime frameDescription
UCSD Performance-based Skills Assessment Total Score (Measures Functional Capacity)3 monthsPerformance-based measure of functional capacity in five domains: Communication, Finance, Recreation Planning, Transportation, and Household Chores Scale ranges from 0-100. Subscales are summed to yield the total score. Higher scores represent better performance.

Secondary

MeasureTime frameDescription
Hopkins Verbal Learning Test Percent Retained3 monthsVerbal list learning task with three learning trials and a delay trial. Percent retained refers to the percentage of items recalled at the delay trial, compared to the third learning trial. Score ranges from 0-100. Higher scores represent better performance.

Countries

United States

Participant flow

Recruitment details

Participants included 89 community-dwelling outpatients. Inclusion criteria were: primary psychotic disorder, age 18 or older, and fluency in English. Exclusion criteria were: dementia, neurological conditions affecting cognition, mental retardation, substance use disorder within the past month, and participation in other intervention trials.

Pre-assignment details

Baseline data were collected before randomization.

Participants by arm

ArmCount
Cognitive Training
Cognitive training group
38
Standard Pharmacotherapy
standard pharmacotherapy with regular clinician
31
Total69

Baseline characteristics

CharacteristicStandard PharmacotherapyCognitive TrainingTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants1 Participants1 Participants
Age, Categorical
Between 18 and 65 years
31 Participants37 Participants68 Participants
Age, Continuous48.8 years
STANDARD_DEVIATION 8.7
44.3 years
STANDARD_DEVIATION 10.1
46.3 years
STANDARD_DEVIATION 9.7
Region of Enrollment
United States
31 participants38 participants69 participants
Sex: Female, Male
Female
10 Participants14 Participants24 Participants
Sex: Female, Male
Male
21 Participants24 Participants45 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 380 / 31
serious
Total, serious adverse events
0 / 380 / 31

Outcome results

Primary

UCSD Performance-based Skills Assessment Total Score (Measures Functional Capacity)

Performance-based measure of functional capacity in five domains: Communication, Finance, Recreation Planning, Transportation, and Household Chores Scale ranges from 0-100. Subscales are summed to yield the total score. Higher scores represent better performance.

Time frame: 3 months

ArmMeasureValue (MEAN)Dispersion
Cognitive TrainingUCSD Performance-based Skills Assessment Total Score (Measures Functional Capacity)82.7 units on a scaleStandard Deviation 8.7
Standard PharmacotherapyUCSD Performance-based Skills Assessment Total Score (Measures Functional Capacity)84.4 units on a scaleStandard Deviation 8
Secondary

Hopkins Verbal Learning Test Percent Retained

Verbal list learning task with three learning trials and a delay trial. Percent retained refers to the percentage of items recalled at the delay trial, compared to the third learning trial. Score ranges from 0-100. Higher scores represent better performance.

Time frame: 3 months

ArmMeasureValue (MEAN)Dispersion
Cognitive TrainingHopkins Verbal Learning Test Percent Retained93.4 units on a scaleStandard Deviation 21.6
Standard PharmacotherapyHopkins Verbal Learning Test Percent Retained85.9 units on a scaleStandard Deviation 19.4

Source: ClinicalTrials.gov · Data processed: Mar 25, 2026